Table 1.
Imatinib | Nilotinib | Dasatinib | Bosutinib | Ponatinib | |
---|---|---|---|---|---|
Hematologic | Neutropenia | Neutropenia, thrombocytopenia | |||
Lab values | Phosphate | Lipase, ALT, AST, blood glucose | Changes in coagulation parameters | ALT, AST, Lipase | Lipase, blood glucose, cholesterol, triglyceride |
Non-lab AEs | Muscle cramps, edema | Rash, PAOD, other vascular events | Pleural effusion, Pulmonal hypertension | Nausea, vomiting, diarrhea | Rash, PAOD, arterial and venous events, arterial hypertension |
Abbreviation: AEs, adverse events; ALT, alanine transaminase; AST, aspartate transaminase; PAOD, peripheral arterial vascular occlusive disease; TKI, tyrosine kinase inhibitors.